NASDAQ
Capricor Therapeutics, Inc. (CAPR) has a free cash flow growth of -39.42% as of Friday, May 29, 2026. This represents a 4.15% increase compared to its 12-month average of -41.13%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.